Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Biochemistry and Nutrition|November 25, 2024
General and sex-specific effects of vitamin D against atrial fibrillation and young-onset ischemic stroke: a Mendelian randomization seriesYap-Hang Chan, Jie V Zhao, C Mary Schooling, et al.
Frontiers in Endocrinology|August 9, 2022
Case Report: Insulinoma Co-Existing With Type 2 Diabetes - Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency AblationJohnny Yau-Cheung Chang, Chariene Shao-Lin Woo, David Tak-Wai Lui, et al.
Plos One|February 4, 2017
Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinomaChi-Ho Lee, Gang Huang, Pak-Hei Chan, et al.
Journal of Neuroinflammation|March 28, 2024
Liver-specific adiponectin gene therapy suppresses microglial NLRP3-inflammasome activation for treating Alzheimer's diseaseRoy Chun-Laam Ng, Min Jian, Oscar Ka-Fai Ma, et al.
Molecular Therapy. Methods & Clinical Development|August 25, 2016
PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retinaJack W Hickmott, Chih-Yu Chen, David J Arenillas, et al.
Human Gene Therapy|August 1, 2018
New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate RetinaElizabeth M Simpson, Andrea J Korecki, Oriol Fornes, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2010
Synthesis, characterization and preliminary analysis of in vivo biological activity of chitosan/celecoxib microcapsulesShuk-Yan Cheng, Marcus Chun-Wah Yuen, Pik-Ling Lam, et al.
Diabetes, Obesity & Metabolism|November 5, 2024
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes-A real-world studyChi-Ho Lee, David Tak-Wai Lui, Lung-Yi Mak, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2021
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and OutcomesDavid Tak Wai Lui, Chi Ho Lee, Vikki Tang, et al.
Pageof 17